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Objective: To validate and compare the decision rules to identify rheumatoid arthritis (RA) 
in administrative databases.
Methods: A study was performed using administrative health care data from a population of 
1 million people who had access to universal health care. Information was available on hospital 
discharge abstracts and physician billings. RA cases in health administrative databases were 
matched 1:4 by age and sex to randomly selected controls without inflammatory arthritis. Seven 
case definitions were applied to identify RA cases in the health administrative data, and their 
performance was compared with the diagnosis by a rheumatologist. The validation study was 
conducted on a sample of individuals with administrative data who received a rheumatologist 
consultation at the Arthritis Center of Nova Scotia.
Results: We identified 535 RA cases and 2,140 non-RA, noninflammatory arthritis controls. 
Using the rheumatologist’s diagnosis as the gold standard, the overall accuracy of the case 
definitions for RA cases varied between 68.9% and 82.9% with a kappa statistic between 0.26 
and 0.53. The sensitivity and specificity varied from 20.7% to 94.8% and 62.5% to 98.5%, 
respectively. In a reference population of 1 million, the estimated annual number of incident 
cases of RA was between 176 and 1,610 and the annual number of prevalent cases was between 
1,384 and 5,722.
Conclusion: The accuracy of case definitions for the identification of RA cases from rheu-
matology clinics using administrative health care databases is variable when compared to a 
rheumatologist’s assessment. This should be considered when comparing results across studies. 
This variability may also be used as an advantage in different study designs, depending on the 
relative importance of sensitivity and specificity for identifying the population of interest to 
the research question.
Keywords: inflammatory arthritis, case definitions, incidence, prevalence, population health
Introduction
The study of chronic disease at a population health level allows estimation of overall 
disease frequency, health care utilization, and associated costs.1 Such information is 
helpful to determine the most appropriate allocation of current and future health care 
resources. Rheumatoid arthritis (RA) is one of the most common chronic autoimmune 
rheumatic diseases.2 It primarily affects young- and middle-aged adults and has serious 
individual and societal consequences if not diagnosed and treated early in the disease 
course.3 Population estimates of this disease provide a basis for estimating current and 
increasing health care needs in the future.
Administrative health care databases that contain information on physician billings, 
hospital visits, and medications are frequently used in the study of population health.4 
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To determine the diagnostic accuracy of this approach, 
various case definitions utilizing different combinations 
of variables have been examined.5,6 However, the optimal 
methodology remains unclear. Our aim was to examine and 
validate a variety of case definitions that can be applied to the 
administrative databases to identify patients with RA.
Methods
study populations and controls
Nova Scotia is a Canadian province of ∼1 million inhabitants. 
There are 2,458 physicians in Nova Scotia, of which 1,227 
work in primary care, 193 are general internists, and eleven 
are adult rheumatologists. Health care services, including 
acute hospitalizations and ambulatory physician visits, are 
universally provided as specified under the Canada Health 
Act. The data were derived from information on Nova Scotia 
residents who were enrolled in the Medical Services Insurance 
program between April 1997 and March 2011. This excludes 
status native Canadians and members of the Canadian armed 
forces. The validation study was conducted on a further subset 
of individuals who had received at least one rheumatologist 
consultation at the Arthritis Center of Nova Scotia.
The data were obtained from existing databases accessed 
through Health Data Nova Scotia in the Department of Com-
munity Health and Epidemiology at Dalhousie University 
in Halifax, Nova Scotia, Canada. Within this unit, there are 
secure research-computing facilities on site, and access to 
data is governed by Health Data Nova Scotia Data Access 
Guidelines and Procedures. The study protocol was reviewed 
and approved by the Capital Health Research Ethics Board. 
Informed consent from individual patients was not required 
as the study utilized secondary administrative data.
Incident cases of RA in the administrative databases 
were defined as those without a physician billing for the 
same diagnosis in the preceding 5 years.7 Prevalent cases 
included both incident and nonincident cases. The average 
annual incidence and prevalence rate was determined between 
April 2002 and March 2011. Patients with RA were matched 
1:4 by age and sex to a control cohort of patients enrolled in 
the same databases but without a diagnosis of RA or other 
inflammatory arthritis (IA). The latter were excluded from 
the control cohort as we wished to distinguish RA from 
noninflammatory musculoskeletal conditions.
Data collection
Individual level data were obtained. Computerized claims 
were linked by encrypted health card number to the Canadian 
Institute of Health Information hospital discharge abstracts 
and Medical Services Insurance physician billings.
comparison of administrative case 
definitions for RA with a rheumatologist’s 
diagnosis
Validation of RA case definitions derived from the admin-
istrative data sets utilized information from rheumatology 
consultations at the Arthritis Center of Nova Scotia. In this 
analysis, the rheumatologist’s diagnosis was taken as the 
gold standard for both RA cases (case-rheum) and con-
trols (control-rheum). The data for the validation exercise 
used patient’s information in the administrative data set 
and information from rheumatology consultations at the 
Arthritis Center identified through the clinic registration 
system. In this way, the analysis was restricted to patients 
who were in both the health administrative data set and 
the medical records of the Arthritis Center. The process 
maintained patient’s confidentiality in compliance with 
Nova Scotia Provincial privacy legislation on use of health 
administrative data. The Arthritis Center is a regional 
resource with eight attending staff rheumatologists, and 
the majority of referrals are received from primary care 
physicians. Although most of the referred patients reside 
in the Capital Health District of Nova Scotia, which has 
40% of the population of the province, a substantial number 
of patients are also referred from each of the other eight 
health districts.
Utilizing the validation data set described earlier, indi-
viduals were identified in the administrative data set who 
fulfilled one or more of the case definitions for RA. Four 
age- and sex-matched controls were identified for each case 
and designated as case-admin and control-admin. Scrambled 
unique identifiers (provincial health card numbers) were 
used to identify cases and controls, which were present in 
both the administrative data set and the Arthritis Center’s 
record of clinic visits. The unique identifiers were then 
descrambled by an authorized third party to permit identi-
fication and review of the medical records in the Arthritis 
Center. To determine the validity of the diagnosis of RA in 
the administrative data, the individuals identified using each 
of the seven case definitions for RA and matched controls 
(case-admin and control-admin) were cross-referenced with 
the clinical diagnosis by a rheumatologist (case-rheum and 
control-rheum), arising from one or more ambulatory rheu-
matology assessments at the Arthritis Center. The clinical 
diagnosis derived through chart review for both cases and 
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controls was taken as the gold standard, and the review was 
done without knowledge of the administrative data for each 
of the seven case definitions. The estimated frequency of RA 
cases in the Arthritis Center’s ambulatory clinics between 
2000 and 2012 was 2,692/25,888 (10.4%) of the total clinic 
population.
Case definitions for identification of 
RA cases and validation
The following seven individual case definitions were used to 
identify the cases of RA in the administrative databases:
#1 MacLean:8 Two physician visits for RA at least 2 months 
apart.
#2 MacLean/Lacaille:7 MacLean algorithm with Lacaille 
variation, ie, excluding individuals with at least two visits, 
at least 2 months apart, subsequent to the second RA visit, 
with two identical diagnoses of other IAs and connective 
tissue diseases (psoriatic arthritis, ankylosing spondyli-
tis, and other spondyloarthropathies, SLE, scleroderma, 
Sjogren’s syndrome, dermatomyositis, polymyositis, 
other connective tissue diseases, and primary systemic 
vasculitis) and excluding those where a diagnosis of RA 
by a nonrheumatologist was not confirmed if/when the 
individual saw a rheumatologist.
#3 Shipton-like: Three RA diagnostic billing codes, over 
any time period, rather than in 3 consecutive years as 
described by Shipton et al.9
#4 Hospitalization: At least one hospitalization where RA 
was in the diagnostic codes.
#5 Rheumatologist: At least one RA code contributed by a 
rheumatologist.
#6 Combination: MacLean-like algorithm (two nonrheuma-
tology physician visits for RA at least 2 months apart, 
within a 2-year period) or at least one RA code contrib-
uted by a rheumatologist or at least one hospitalization 
where RA was in the diagnostic codes and Lacaille varia-
tion, ie, excluding individuals with at least two visits, at 
least 2 months apart, subsequent to the second visit, with 
two identical diagnoses of other IAs and connective tis-
sue diseases (psoriatic arthritis, ankylosing spondylitis, 
and other spondyloarthropathies, SLE, scleroderma, 
Sjogren’s syndrome, dermatomyositis, polymyositis, 
other connective tissue diseases, and primary systemic 
vasculitis) and excluding those where a diagnosis of RA 
by a nonrheumatologist was not confirmed if/when the 
individual saw a rheumatologist.
#7 Single admin: Any single diagnostic code for RA.
The following International Classification of Diseases, 
Ninth Edition (ICD-9) and International Classification 
of Diseases, Tenth Edition (ICD-10) diagnostic codes 
were used:
RA 
 (ICD-9: 714.0, 714.1, and 714.2. ICD-10: MO5–MO5.9, 
MO6.0, MO6.8, and MO6.9).
Systemic lupus erythematosus 
 (ICD-9: 710.0. ICD-10: ICD-10: M 32, M32.1, M32.8, 
and M32.9).
Psoriatic arthritis 
 (ICD-9: 696.0. ICD-10: L40.5).
Ankylosing spondylitis 
 (ICD-9: 720.0. ICD-10: M45).
Other spondyloarthritides 
 (ICD-9: 720.1, 720.2, 720.8, and 720.9. ICD-10: M46.0, 
M46.1, M46.2, M46.3, M46.4, M46.5 M46.8, and 
M46.9).
Scleroderma 
 (ICD-9: 710.1. ICD-10: M34).
Sjogren’s syndrome 
 (ICD-9: 710.2. ICD-10: M35.0).
Dermatomyositis 
 (ICD-9: 710.3. ICD-10: M33.1 and M33.9).
Polymyositis 
 (ICD-9: 710.4. ICD-10: M33.2).
Other connective tissue diseases 
 (ICD-9: 710.5, 710.8, and 710.9. ICD-10: M35.1, M35.2, 
M35.8, and M35.9).
Primary systemic vasculitis 
 (ICD-9: 446.0, 446.2, 446.4, 446.5, 446.7, and 447.6. 
ICD-10: D69.0, M31.0, M30.0, M31.3, M31.4, M31.5, 
M31.6, M31.7, M31.8, and M31.9).
statistical analysis
The data were analyzed with SAS Version 8.3 software 
(SAS Institute Inc., Cary, NC, USA). Descriptive statistics 
were used to characterize the case and control cohorts. 
The sensitivity, specificity, and overall accuracy, positive, 
and negative predictive values of the seven case definitions 
for RA using administrative data were determined using 
the diagnosis made by rheumatology consultation as the 
gold standard. The extent of agreement was expressed by 
simple kappa coefficient (0.01–0.2 indicates slight agree-
ment, 0.21–0.4 is fair, 0.41–0.6 is moderate, 0.61–0.8 is 
substantial agreement, and 0.81–0.99 is almost perfect 
agreement).10
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Results
cases and controls
From the administrative databases, a total of 535 RA case-
admins were identified, all of whom had been seen by at 
least one rheumatologist in the Arthritis Center. In addition, 
2,140 control-admins matched 4:1 to case-admins by age and 
sex were identified in the administrative databases that had 
an evaluation at the Arthritis Center (Table 1). Case-admins 
and control-admins were well matched for age and sex. These 
data provided the basis for validation of the case-admins’ 
definitions for RA.
Identification of RA cases
The overall accuracy of the case definitions for the correct 
identification of RA case-admins (Table 2) varied between 
68.9% and 82.9% with a kappa statistic between 0.26 and 
0.53. The sensitivity and specificity of the case-admin defi-
nitions varied from 20.7% to 94.8% and 62.5% to 98.5%, 
respectively.
Impact of case definitions on incidence 
and prevalence rate of RA
To illustrate the potential impact of the different case-admin 
definitions, the estimated mean number of annual incident 
and prevalent cases of RA from 2002 to 2011 determined 
using the seven case-admin definitions are illustrated in 
Figure 1. The number of incident RA cases per year by case 
definition varied between 176 and 1,610. Given a mean 
population of 941,500 for Nova Scotia over the study period, 
this represents an annual incidence rate of 0.02%–0.17% for 
RA. The number of prevalent cases per year by case defini-
tion varied between 1,384 and 5,722 (0.15%–0.61% annual 
prevalent rate for Nova Scotia population).
Discussion
Administrative health care databases are repositories of clini-
cal information, which may be used to evaluate the frequency 
of disease, utilization, and cost of health care resources in 
a population.1 The value of any population health data set 
is influenced by a number of factors, such as the model of 
health care delivery, access to health services, and geographic 
stability of the population under study.11–13 In addition, the 
validity of case definitions of disease and diagnostic groups 
is critical. Previous studies of RA have used a variety of 
methodological approaches to identify cases in administrative 
data sets, some of which have been validated through linkage 
to clinical data.11 In the current study, we compared seven 
case definitions utilizing data from administrative health care 
databases in an urban/rural environment of ∼1 million people, 
most of whom had access to universal health care. There were 
substantial differences between the case definitions in the 
accuracy of RA ascertainment and the consequent estimates 
of disease frequency. Our findings have implications for the 
use of administrative health care databases in the study of 
RA at a population health level.
Over the past 30 years, a number of studies have vali-
dated a variety of case definitions, consisting of single items 
or combinations thereof, for the identification of rheumatic 
diseases in administrative databases.11,14–20 The results 
demonstrate a wide range in standard epidemiological mea-
sures, such as sensitivity, specificity, positive, and negative 
predictive values. The reason is due in part to not only the 
Table 1 Demographic features of patients with RA and matched 
controls from health care administrative databases
Variable RA cases Controls P-value
number 535 2,140
Age, mean (sD) (years) 56.0 (17.8) 56.0 (17.8) ns*
Female sex (%) 67.9 67.9 ns*
Abbreviations: RA, rheumatoid arthritis; SD, standard deviation; NS, not significant.
Note: *, P0.05.
Table 2 Agreement, sensitivity, specificity, accuracy, and predictive value of RA case definitions using administrative health care 
databases
Decision rule Kappa  
(95% CI)
Sensitivity  
(95% CI)
Specificity  
(95% CI)
Accuracy  
(95% CI)
Positive  
predicted value  
(95% CI)
Negative 
predicted value 
(95% CI)
#1 Maclean 0.52 (0.46, 0.56) 83.0 (79.8, 86.2) 80.8 (79.1, 82.5) 81.2 (79.4, 83.0) 51.9 (48.6, 55.3) 95.0 (94.0, 96.0)
#2 Maclean-lacaille 0.42 (0.38, 0.46) 68.8 (64.9, 72.7) 80.8 (79.1, 82.5) 78.3 (76.5, 80.2) 47.2 (43.7, 50.7) 91.2 (90.0, 92.5)
#3 shipton 0.53 (0.50, 0.57) 83.2 (80.0, 86.3) 81.6 (80.0, 83.2) 81.9 (80.2, 83.7) 53.0 (49.7, 56.4) 95.1 (94.1, 96.1)
#4 hospitalization 0.26 (0.22, 0.31) 20.7 (17.3, 24.2) 98.5 (97.9, 99.0) 82.9 (91.5, 84.4) 77.1 (70.2, 83.9) 83.2 (83.2, 84.7)
#5 Rheumatologist 0.48 (0.44, 0.51) 87.7 (84.9, 90.5) 75.5 (73.7, 77.3) 77.9 (76.0, 80.0) 47.2 (44.1, 50.3) 96.1 (95.1, 97.0)
#6 combination 0.49 (0.46, 0.52) 92.0 (89.7, 94.3) 74.3 (72.4, 76.1) 77.8 (75.8, 79.8) 47.2 (44.1, 50.2) 97.4 (96.6, 98.1)
#7 single admin 0.37 (0.34, 0.40) 94.8 (92.9, 96.7) 62.5 (60.4, 64.5) 68.9 (66.5, 71.4) 38.7 (36.1, 41.3) 98.0 (97.2, 98.7)
Abbreviations: CI, confidence interval; RA, rheumatoid arthritis.
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inherent differences between case definitions but also the 
methodological design of the validation strategy, including 
the selection of cases and controls (eg, general population 
or specialty clinics), diagnostic confirmation of cases (eg, 
patient self-report, classification criteria, or case definition), 
and blinding of assessors. In this study, cases and controls 
identified in the administrative databases were compared with 
the clinical diagnosis made by a rheumatologist.
A review of 12 studies11 that validated case definitions 
for the identification of RA in administrative data sets indi-
cates a wide range in sensitivity (8.3%–100%), specificity 
(27.0%–99.7%), positive (55.7%–95.0%), and negative 
(92.4%–100%) predictive values. In this study, variability 
in the performance of case definitions was also apparent, 
although less than that reported for RA in previous studies.
The prevalence rate of RA is felt to be between 0.50% 
and 1.0% of the general population,2 and our findings 
(0.15%–0.61%) overlap with this albeit on the lower side. In a 
study from another large Canadian population, the prevalence 
rate of RA was 0.76%7 compared to 0.37% in our population 
using the same case definition (#2 MacLean-Lacaille deci-
sion rule).7 The difference is due in part to the exclusion of 
juvenile onset IA in our study but not in the study by Lacaille 
et al.7 The lower disease prevalence rates for RA may also 
reflect the relative paucity of adult rheumatologists in Nova 
Scotia during the study period and reduced access to rheu-
matology services.
Differences in performance of the diagnostic case 
definitions have a significant impact on the estimation of 
the frequency of incident and prevalent RA cases. This is 
not altogether surprising. For example, given the nature of 
rheumatic diseases, it is to be expected that hospitalization 
data (case definition #4) would provide the lowest sensitivity 
for the detection of RA. On the other hand, the same case 
definition provides the highest specificity for RA cases. It is 
likely that this population includes patients with the greatest 
disease severity and the highest health care utilization and 
costs. Conversely, the case definition that relies solely on a 
single physician billing provides the highest sensitivity and 
lowest specificity for RA and likely includes patients with 
milder clinical disease phenotypes. Rather than a weakness, 
the variability in the performance of the different diagnos-
tic case definitions is a potential strength, as it provides an 
opportunity to select a specific case definition a priori for its 
known sensitivity and specificity or to utilize a range of case 
definitions as a form of sensitivity analysis.
There are some limitations to the current study. First, 
although it would have been preferable not to restrict the 
validation of RA cases to patients assessed at a rheumatology 
clinic, the confirmation of cases and controls in primary care 
and nonrheumatology specialty settings was not feasible, in 
large part due to privacy legislation in Nova Scotia. Second, 
the criteria for selection of controls in our study preclude 
an assessment of the case definitions to distinguish between 
RA incidence and prevalence
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Figure 1 The mean annual incidence and prevalence rate of RA from 2002 to 2011 determined from health care administrative data using seven case definitions. 
Abbreviation: RA, rheumatoid arthritis.
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RA and other IAs as the latter were deliberately excluded 
from the control group. Third some “false negatives” (ie, 
a patient with RA confirmed by a rheumatologist but not 
captured by any of the seven case definitions) may not 
have been included in the control groups, which, except 
for age and sex, were randomly matched 4:1 and excluded 
individuals with IA. However, the likelihood of a patient 
with RA not receiving a single physician billing diagnosis 
of RA over the 9 years of the study is low. This is one of the 
advantages of using seven case definitions for RA, which 
to our knowledge no other study has done. Fourth, the 
rheumatology clinic population is understandably enriched 
for RA cases, compared to the general population, which 
limits the reliability of estimating both positive and negative 
predictive values. These results were included to comply 
with the recent recommendations11 arising from a systematic 
review of validation studies to identify rheumatic diseases in 
health administrative databases. Fifth, the generalizability of 
sensitivity and specificity in the study is limited to the use 
of RA case definitions based on the diagnostic codes from 
rheumatologists. Finally, it would be of interest to know the 
performance of these case definitions in the identification 
of other rheumatic disease entities.
Conclusion
The accuracy of case definitions for the identification of 
RA cases from rheumatology clinics using administra-
tive health care databases is variable when compared to a 
rheumatologist’s assessment. This has both advantages and 
disadvantages in the study of this chronic disease. The results 
of the current study provide a foundation to examine several 
important issues, including health care utilization and associ-
ated costs, in patients with RA.
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